Search

everythinglearnresearchcommunity

for

Search:↓

Low-level laser therapy did not reduce licking or improve lesions in dogs with ALD but did increase hair growth.

The document discusses a young boy with autism and early puberty but does not provide a conclusion on managing his behavior.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

A girl's hair-pulling condition improved greatly after she started vitamin D treatment.

Cognitive behavioral strategies help women with PCOS make lifestyle changes to improve their health.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.

Blood pressure drugs can cause skin lupus, but it improves after stopping the drug. The glycoprotein D vaccine works against genital herpes in some women, and the HPV-16 vaccine reduces HPV-16 infection and related diseases. More frequent light therapy clears psoriasis faster. A cream called imiquimod effectively treats a type of skin cancer. Iron supplements don't necessarily help with chronic hair loss in women.

A drug improved schizophrenia-like symptoms in stressed rats by changing brain steroid levels.

Avoid alcohol, ponytails, and oily scalp, and get good sleep to prevent severe hair loss.

The conclusion is that finasteride is linked to an increased risk of suicidal thoughts and a higher risk of completed suicide when used for hair loss.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Changing allopregnanolone levels in baby rats affects their adult behavior and alcohol use.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

MC-DNA vector-based gene therapy can temporarily treat CBS deficiency in mice.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Group behavior therapy reduces hair-pulling symptoms more than supportive therapy but has limited long-term effectiveness.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Behavior therapy and medications, especially clomipramine, can help reduce hair pulling in people with trichotillomania.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Hormone therapy in transgender women can affect hair growth and acne, and there are specific skin issues related to gender-affirming surgery, but more research is needed on their dermatological health.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.